PURPOSE To assess whether diverse tumor location(s) show differences in percutaneous cryoablation (PCA) outcomes of cancer control, morbidity, and ablation volume reduction for many soft-tissue tumor types. MATERIALS AND METHODS A total of 220 computed tomography (CT)- and/or ultrasonography-guided percutaneous cryotherapy procedures were performed for 251 oligometastatic tumors from multiple...

Journal Roundup: Recent Developments in Tumor Ablation June 08, 2005 | Tumor Ablation [1] Journal articles published since the beginning of this year look at new treatment modalities, provide more evidence of ablation’s efficacy, and identify potential complications. Imaging technologies and combination therapies are also covered. */ Journal articles published since the beginning of this year l...

Journal Roundup: Recent Developments in Tumor Ablation June 08, 2005 | Tumor Ablation [1] Journal articles published since the beginning of this year look at new treatment modalities, provide more evidence of ablation’s efficacy, and identify potential complications. Imaging technologies and combination therapies are also covered. */ Journal articles published since the beginning of this year l...

Journal Roundup: Recent Developments in Tumor Ablation June 08, 2005 | Tumor Ablation [1] Journal articles published since the beginning of this year look at new treatment modalities, provide more evidence of ablation’s efficacy, and identify potential complications. Imaging technologies and combination therapies are also covered. */ Journal articles published since the beginning of this year l...

PURPOSE We aimed to compare local and metastatic recurrence of small renal masses primarily treated by cryoablation or microwave ablation. MATERIALS AND METHODS The MEDLINE, CINAHL, and PUBMED databases were searched to review the treatment of small renal masses with cryoablation or microwave ablation. Fifty-one studies met the inclusion criteria. RESULTS Fifty-one studies representing 3950...

PURPOSE To determine oncologic outcomes and predictors of primary efficacy, including RENAL nephrometry scores (radius, exophytic/endophytic properties, nearness of tumor to collecting system or sinus, anterior/posterior, location relative to polar lines), after percutaneous radiofrequency (RF) ablation of proven renal cell carcinoma (RCC). MATERIALS AND METHODS Patients who underwent percuta...

Tumor metastases are the basic biological characteristics of malignant tumors, and the lungs are the second most prominent metastatic organs in which these develop after the liver. Currently, with the rapid development of ablation technology, ablation therapy as a local treatment is playing an increasingly important role in the treatment of lung metastases. Whether alone or in combination with ...

Radiofrequency ablation (RFA) is a thermal technique widely used for the management of benign thyroid nodules. To date, five academic societies in various countries have reported clinical practice guidelines, opinion statements, or recommendations regarding use RFA. However, despite some similarities, there are also differences among and consensus required safe effective treatment Asian countri...

We developed a combined system of tumor detection by 5-ALA-induced PpIX fluorescence and precise ablation by micro laser for the first time, with an automatic focusing and robotic scanning mechanism for the brain surface. 5-ALA accumulates on tumors to be metabolized to become PpIX that is a fluorescent. Intra-operative detection of 5-ALA induced PpIX fluorescence provides useful information fo...

OBJECTIVE Evaluate the success rate of first high dose 100 mCi (3.7 GBq) radioiodine remnant ablation (RRA) in low-risk differentiated thyroid cancer (DTC) patients after surgery and determine factors influencing the success. MATERIAL AND METHOD Between 1994 and 2011, a retrospective analysis was performed of 166 low-risk DTC patients after surgery (age range 18-76 years, mean age 38 years, 1...